PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
PROCEPT BioRobotics (Nasdaq: PRCT) announced management will present at three investor conferences in May and June 2026: Bank of America Health Care (May 12, Las Vegas), William Blair Growth Stock (June 2, Chicago) and Truist Med‑Tech (June 16, Boston).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PROCEPT BioRobotics (Nasdaq: PRCT) announced management will present at three investor conferences in May and June 2026: Bank of America Health Care (May 12, Las Vegas), William Blair Growth Stock (June 2, Chicago) and Truist Med‑Tech (June 16, Boston).
Live webcasts and archived recordings will be available on the company Investors website and will remain accessible for at least 90 days after each event.
Details
News Market Reaction – PRCT
On May 1, the first trading day after this news, PRCT closed 2.45% above the previous close.
Data tracked by StockTitan Argus for the May 1 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN JOSE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of management will present at three upcoming investor conferences in May and June.
2026 Bank of America Health Care Conference
- Location – Las Vegas, NV
- Fireside Chat – Tuesday, May 12 at 3:40pm PT / 6:40pm ET
46th Annual William Blair Growth Stock Conference
- Location – Chicago, IL
- Presentation – Tuesday, June 2 at 12pm CT / 1pm ET
2026 Truist Med-Tech Conference
- Location – Boston, MA
- Fireside Chat – Tuesday, June 16 at 1:40am ET
A live webcast of each event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com. The webcasts will be archived and available for replay for at least 90 days after the event.
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics manufactures the AQUABEAM® and HYDROS® Robotic Systems. The HYDROS Robotic System is the only AI-powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with approximately 250 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.
Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@procept-biorobotics.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.